P3 Health Partners

Q2 FY2026 EarningsQ2 FY26 performance significantly outperformed consensus across top and bottom-line metrics, highlighted by a revenue beat of $386M vs. $377.8M expected and a sharp pivot to GAAP net income of $15.7M compared to an anticipated loss of $7M. The beat was primarily driven by a 15% YoY increase in per-member capitated revenue and favorable payer settlements. Consequently, management raised the full-year 2026 Adjusted EBITDA guidance to $80M–$110M, signaling a structural inflection in profitability.